Media Advisory: J. Craig Venter, Ph.D to Receive the 2016 BIO George Washington Carver Award
What: Dr. Craig Venter will deliver remarks and will be presented the George Washington Carver Award by the Biotechnology Innovation Organization (BIO) at the 2016 World Congress on Industrial Biotechnology in San Diego on Monday, April 18. The George Washington Carver Award is presented annually to honor an individual for carrying on the legacy of Carver, who was one of the founding fathers of the chemurgy movement, a branch of applied chemistry focused on manufacturing industrial products from raw agricultural materials.
Background: A special selection committee of scientists and leaders in the field chose Venter for opening new outlooks on impactful applications in a biobased economy and for industrial sustainability. Dr. Venter’s contributions to the sequencing of Haemophilous influenzae in 1995 and of the human genome in 2000 stand as two major milestones of biology’s new era. As an academic scientist and an entrepreneur, Dr. Venter has formed and led several organizations including The Institute for Genomic Research (TIGR), JCVI, Synthetic Genomics Inc. (SGI), and his most recent company Human Longevity Inc. which promises to revolutionize health care practices and delivery. In all his undertakings he has formed and led multiple teams that have risen to the scientific challenges because of his unique abilities to motivate and inspire.
The Iowa Biotechnology Association is the sponsor of the 2016 BIO George Washington Carver Award.
All programs at the World Congress on Industrial Biotechnology are open to attendance by members of the media. Complimentary media registration is available to editors and reporters working full time for print, broadcast or web publications with valid press credentials.
For more information on the conference, please visit http://go.bio.org/WorldCongress2016.html. For assistance, please contact worldcongress@bio.org.
About BIO
BIO is the premier biotechnology advocacy organization representing biotech companies, industry leaders, and state biotech associations in the United States and more than 35 countries around the globe. BIO members range from biotech start-ups to some of the world’s largest biopharmaceutical companies – all united by the same goal: to develop medical and scientific breakthroughs that prevent and fight disease, restore health, and improve patients’ lives. BIO also organizes the BIO International Convention and a series of annual conferences that drive partnerships, investment, and progress within the sector. Learn more at bio.org.